Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: E9ACK3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 159 | 163 | PF00656 | 0.631 |
CLV_NRD_NRD_1 | 168 | 170 | PF00675 | 0.693 |
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.699 |
CLV_PCSK_FUR_1 | 146 | 150 | PF00082 | 0.574 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.502 |
CLV_PCSK_PC1ET2_1 | 148 | 150 | PF00082 | 0.500 |
CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.507 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.386 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.538 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.418 |
DOC_PP1_RVXF_1 | 22 | 28 | PF00149 | 0.534 |
DOC_PP2B_LxvP_1 | 73 | 76 | PF13499 | 0.448 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.614 |
DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.481 |
DOC_USP7_MATH_1 | 49 | 53 | PF00917 | 0.488 |
DOC_USP7_MATH_1 | 82 | 86 | PF00917 | 0.732 |
DOC_USP7_UBL2_3 | 124 | 128 | PF12436 | 0.529 |
DOC_USP7_UBL2_3 | 170 | 174 | PF12436 | 0.637 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.577 |
LIG_14-3-3_CanoR_1 | 116 | 120 | PF00244 | 0.596 |
LIG_14-3-3_CanoR_1 | 92 | 99 | PF00244 | 0.594 |
LIG_BRCT_BRCA1_1 | 85 | 89 | PF00533 | 0.595 |
LIG_CSL_BTD_1 | 25 | 28 | PF09270 | 0.452 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.559 |
LIG_FHA_2 | 12 | 18 | PF00498 | 0.561 |
LIG_FHA_2 | 93 | 99 | PF00498 | 0.518 |
LIG_LIR_Nem_3 | 52 | 58 | PF02991 | 0.437 |
LIG_SH3_3 | 162 | 168 | PF00018 | 0.602 |
LIG_SUMO_SIM_par_1 | 69 | 78 | PF11976 | 0.445 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.644 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.583 |
MOD_CK1_1 | 85 | 91 | PF00069 | 0.589 |
MOD_CK2_1 | 161 | 167 | PF00069 | 0.749 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.633 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.580 |
MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.606 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.546 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.397 |
MOD_PIKK_1 | 59 | 65 | PF00454 | 0.324 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.540 |
MOD_Plk_1 | 161 | 167 | PF00069 | 0.595 |
MOD_Plk_4 | 161 | 167 | PF00069 | 0.591 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.574 |
MOD_SUMO_for_1 | 147 | 150 | PF00179 | 0.543 |
MOD_SUMO_rev_2 | 167 | 176 | PF00179 | 0.660 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.392 |
TRG_NES_CRM1_1 | 63 | 77 | PF08389 | 0.419 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJ04 | Leptomonas seymouri | 64% | 98% |
A0A0S4INX7 | Bodo saltans | 42% | 90% |
A0A1X0P8U1 | Trypanosomatidae | 38% | 91% |
A0A3S5H549 | Leishmania donovani | 95% | 100% |
A0A422NMF6 | Trypanosoma rangeli | 41% | 95% |
A4H3M0 | Leishmania braziliensis | 86% | 99% |
D0A262 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 79% |
E9AG47 | Leishmania infantum | 95% | 100% |
E9AJU1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |